Sara Elizabeth O'donnell, Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 5179 Lodgecliffe Ln, Mcfarland, WI 53558 Phone: 608-834-0414 |
Theresa M Lenaghan, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6121 Shooting Star Trl, Mcfarland, WI 53558 Phone: 608-333-8921 |
Amie Neumaier Marie Neumaier, APNP Nurse Practitioner - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 4717 Dale Curtin Dr, Mcfarland, WI 53558 Phone: 608-838-1772 |
Ms. Devon Kay Christenson, NP Nurse Practitioner - Pediatrics, Critical Care Medicare: Not Enrolled in Medicare Practice Location: 6303 Pheasant Run, Mcfarland, WI 53558 Phone: 608-669-2859 |
Jaclyn A Miller, NP Nurse Practitioner - Neonatal, Critical Care Medicare: Not Enrolled in Medicare Practice Location: 4510 Catalina Pkwy, Mcfarland, WI 53558 Phone: 720-290-1976 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and Montana State University have discovered a fungal protein that plays a key role in causing disease in plants and animals and which also shields the pathogen from oxidative stress.
"Gender discrimination lies behind much of the malnutrition found in under-five children in Nepal, say locals and experts," IRIN reports. "Women live hard lives from day one, born with no fanfare, contrasting starkly to the six-day celebration to mark the birth of a boy.
Late-breaking Novo Nordisk extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association showed that once-daily Victoza in combination with metformin produced sustained and significantly greater reductions in A1c, body weight and fasting plasma glucose than Januvia plus metformin at 52 weeks.
› Verified 4 days ago